Boehringer Ingelheim Introduces IDBS’ E-WorkBook Suite
News Oct 29, 2014
Boehringer Ingelheim has introduced IDBS’ E-WorkBook Suite to eliminate data silos in the lab. The cross-domain platform has initially been deployed in North America with the next roll-out planned for Germany. Users are benefiting from streamlined research and development (R&D) with increases in data quality and productivity.
With E-WorkBook, Boehringer Ingelheim scientists can easily and simply capture and record data electronically. Information is both searchable and retrievable for better data sharing and efficiency. Multiple systems are being consolidated for a centralized and highly configurable data flow.
“We are building on our drug discovery excellence combined with a strong focus on external innovation for novel mechanisms and new therapeutic modalities” said Thomas Reith, Head of IT Research & Development and Medicine at Boehringer Ingelheim. “We were looking for an electronic lab notebook that could meet these needs and enables us to derive value from our data across all of our domains including research, development and animal health. IDBS has exceeded our expectations during the pilot program and we can now retire multiple in-house solutions to support our future growth on a global basis.”
“Data quality and cost reduction are both big challenges for the life sciences industry,” said Scott Weiss, Director of Product Strategy at IDBS. “The ability to connect diverse data sources including paper, lab tools and in-house solutions on a comprehensive platform is an attractive proposition to tackle these issues. As firms like Boehringer Ingelheim look to harmonize their data landscape, the flexibility of E-WorkBook’s cross-domain functionalities come into their own.”
Over the next few years, the system is planned to be rolled out to up to 2,400 users globally. The company will also look to integrate E-WorkBook with existing lab infrastructure as well as external LIMs, SAP and data management systems.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019